ThinkGenetic, Inc., is proud to be exhibiting alongside Emory Genetics Laboratory at the Manchester Grand Hyatt San Diego the week of February 29 – March 4, 2016 to demonstrate the beta of ThinkGenetic. This smart question & answer app powered by IBM Watson is designed to help doctors and patients with difficult-to-diagnose rare, genetic diseases. With over 7,000 rare genetic diseases in its database, ThinkGenetic will be the leader in solving often overlooked or near impossible genetic medical issues, while assisting the pharmaceutical industry in directing orphan drugs (rare disease drugs) to people in need.
“The goal of the WORLDSymposia is to provide an interdisciplinary forum to explore and discuss specific areas of interest, research and clinical applicability related to lysosomal diseases. Each year, WORLDSymposia hosts a scientific meeting presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases. This symposium is designed to help researchers and clinicians to better manage and understand diagnostic options for patients with lysosomal diseases, identify areas requiring additional basic and clinical research, public policy and regulatory attention, and identify the latest findings in the natural history of lysosomal diseases.”
If you are attending the event and wish to discuss potential investor or partnering opportunities, please contact Dave Jacob at djacob@thinkgenetic.com. For database and rare genetic disease questions contact Dawn Laney at dawn.laney@emory.edu.
